Type 2 Diabetes Mellitus
📧 Sign up to get email alerts when something new happens for Type 2 Diabetes Mellitus.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2012-05-21Clinical Trial Update: Safety and Tolerability of Pioglitazone-Azilsartan in Subjects With Type 2 Diabetes [Phase 3]
A Phase 3 trial assessing the safety and tolerability of a pioglitazone-azilsartan combination in adults with type 2 diabetes was terminated…
-
CLINICAL_TRIALS trial_result · 2012-05-18Clinical Trial Update: Phase III Trial to Evaluate the Efficacy and Safety of LC15-0444 Compared With Sitagliptin Added to Ongoing Metformin Therapy in Patients With Type 2 Diabetes [Phase 3]
A Phase 3 trial comparing LC15-0444 with sitagliptin added to ongoing metformin therapy in adults with type 2 diabetes has completed.
-
CLINICAL_TRIALS trial_result · 2012-05-18Clinical Trial Update: Phase 3 Trial to Evaluate the Efficacy and Safety of LC15-0444 in Patients With Type 2 Diabetes [Phase 3]
A Phase 3 trial evaluating the efficacy and safety of LC15-0444 in patients with Type 2 Diabetes Mellitus has completed.
-
CLINICAL_TRIALS research · 2012-05-18Clinical Trial Update: A Study To Evaluate PF-05175157 In Healthy Volunteers [Phase 1]
Pfizer conducted a Phase 1 study of PF-05175157 in healthy volunteers to assess safety and pharmacology for potential use in Type 2 diabetes…
-
FDA approval · 2012-05-17FDA Approved: ACTOS — Supplemental Application (Takeda Pharmaceuticals America, Inc.)
FDA approved a supplemental application for ACTOS (pioglitazone) submitted by Takeda Pharmaceuticals America, Inc.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2012-05-17FDA Approved: PIOGLITAZONE AND GLIMEPIRIDE — Supplemental Application (Prasco Laboratories)
FDA approved a supplemental application for a pioglitazone and glimepiride combination product from Prasco Laboratories.
-
FDA approval · 2012-05-17FDA Approved: ACTOPLUS MET — Supplemental Application (Takeda Pharmaceuticals America, Inc.)
The FDA approved a supplemental application for ACTOPLUS MET (pioglitazone and metformin hydrochloride) by Takeda Pharmaceuticals America, I…
-
CLINICAL_TRIALS trial_result · 2012-05-16Clinical Trial Update: Study of the Safety and Biologic Activity of XOMA 052 in Subjects With Type 2 Diabetes Mellitus [Phase 2]
This update reports the results of a Phase 2 study evaluating the safety and biologic activity of XOMA 052 in adults with Type 2 Diabetes Me…
-
CLINICAL_TRIALS trial_result · 2012-05-15Clinical Trial Update: Effects of Nasulin Versus Placebo on Blood Glucose Control in Patient Volunteers With Type 2 Diabetes Mellitus [Phase 2]
A Phase 2 trial compared Nasulin to placebo for improving blood glucose control in adults with Type 2 diabetes mellitus, with results posted…
-
CLINICAL_TRIALS trial_result · 2012-05-15Clinical Trial Update: Cardiovascular Effects of Chronic Sildenafil in Men With Type 2 Diabetes [Phase 4]
Phase 4 trial update evaluating the cardiovascular effects of chronic sildenafil in men with type 2 diabetes, with results posted in 2012.
-
CLINICAL_TRIALS trial_result · 2012-05-11Clinical Trial Update: A Retrospective Study of Cardiovascular Events Related to the Use of Glucose Lowering Drug Treatment in Primary Care
A retrospective analysis examining cardiovascular events among patients with type 2 diabetes treated with glucose-lowering therapies in prim…
-
CLINICAL_TRIALS trial_result · 2012-05-10Clinical Trial Update: The Clinical and Economic Impacts of e-Heath on Diabetes [NA]
This trial update reports on the clinical and economic impacts of e-Health tools on diabetes management in type 2 diabetes, with the study s…
-
CLINICAL_TRIALS trial_result · 2012-05-10Clinical Trial Update: Postprandial Insulin Secretion, Oxidative Stress and Gastrointestinal Peptides in Patients With Type 2 Diabetes Versus Healthy Subjects [NA]
The study was completed and compared postprandial insulin secretion, oxidative stress, and gastrointestinal peptide responses in adults with…
-
CLINICAL_TRIALS trial_result · 2012-05-09Clinical Trial Update: Comparison of Metformin and Pioglitazone Effects on Adipokines Concentrations in Newly Diagnosed Type 2 Diabetes Patients [NA]
A completed clinical trial comparing the effects of metformin and pioglitazone on adipokine concentrations in newly diagnosed type 2 diabete…
-
CLINICAL_TRIALS trial_result · 2012-05-08Clinical Trial Update: A Single-Dose Crossover Study of MK0893 in Patients With Type 2 Diabetes (0893-019 AM4)(COMPLETED) [Phase 1]
This Phase 1, single-dose crossover study of MK0893 in patients with Type 2 Diabetes Mellitus has completed and results were posted in 2012.…
-
CLINICAL_TRIALS trial_result · 2012-05-08Clinical Trial Update: Healing Profile of Titanium Dental Implants Placed in Patients With Diabetes [NA]
This clinical trial update reports on the healing performance of titanium dental implants placed in patients with Type 2 diabetes; the study…
-
CLINICAL_TRIALS research · 2012-05-08Clinical Trial Update: Trial of Different Dosages' Ge Gen Qin Lian Decoction in the Treatment of Type 2 Diabetes [NA]
Clinical trial evaluating different dosages of Ge Gen Qin Lian Decoction for the treatment of type 2 diabetes.
-
CLINICAL_TRIALS trial_result · 2012-05-07Clinical Trial Update: A Study to Evaluate the Effect of Vildagliptin on the Maximum Insulin Secretion in Patients With Type 2 Diabetes [Phase 3]
A Phase 3 trial evaluating the effect of vildagliptin on maximum insulin secretion in patients with Type 2 diabetes has completed.
-
CLINICAL_TRIALS trial_result · 2012-05-07Clinical Trial Update: Efficacy and Safety of Vildagliptin in Patients With Type 2 Diabetes With HbA1c 9-11% [Phase 3]
A Phase 3 clinical trial evaluating the efficacy and safety of vildagliptin in adults with type 2 diabetes and HbA1c 9-11% has completed.
-
CLINICAL_TRIALS trial_result · 2012-05-07Clinical Trial Update: Efficacy and Safety of Vildagliptin in Combination With Glimepiride in Patients With Type 2 Diabetes [Phase 3]
A Phase 3 trial evaluated the efficacy and safety of combining vildagliptin with glimepiride in patients with Type 2 diabetes, and the study…
-
CLINICAL_TRIALS trial_result · 2012-05-07Clinical Trial Update: Efficacy and Safety of Vildagliptin in Combination With Insulin in Patients With Type 2 Diabetes [Phase 3]
Phase 3 trial evaluating the efficacy and safety of adding vildagliptin to insulin therapy in adults with type 2 diabetes; the study status …
-
CLINICAL_TRIALS trial_result · 2012-05-07Clinical Trial Update: Efficacy and Safety of Vildagliptin Compared to Placebo in Patients With Type 2 Diabetes and Mild Hyperglycemia [Phase 3]
Phase 3 trial results comparing vildagliptin to placebo in adults with type 2 diabetes and mild hyperglycemia evaluating efficacy and safety…
-
CLINICAL_TRIALS trial_result · 2012-05-07Clinical Trial Update: Efficacy and Safety of Vildagliptin Compared to Acarbose in Drug Naive Patients With Type 2 Diabetes [Phase 3]
A Phase 3 trial comparing the efficacy and safety of vildagliptin versus acarbose in drug-naive adults with type 2 diabetes has completed, s…
-
CLINICAL_TRIALS trial_result · 2012-05-07Clinical Trial Update: Efficacy and Safety of Vildagliptin Compared to Metformin in Drug Naive Patients With Type 2 Diabetes [Phase 3]
A Phase 3 trial compared vildagliptin to metformin in drug-naive adults with Type 2 diabetes to assess efficacy and safety. The study has co…
-
CLINICAL_TRIALS trial_result · 2012-05-07Clinical Trial Update: Multiple Ascending Dose Trial of BYK324677 in Healthy Volunteers [Phase 1]
Phase 1 multiple ascending dose study of BYK324677 in healthy volunteers has completed. The study is associated with Type 2 Diabetes Mellitu…